These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 14657387)

  • 21. Structural and functional analysis of the membrane-spanning domain of the human immunodeficiency virus type 1 Vpu protein.
    Tiganos E; Friborg J; Allain B; Daniel NG; Yao XJ; Cohen EA
    Virology; 1998 Nov; 251(1):96-107. PubMed ID: 9813206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.
    Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB
    Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degradation of SAMHD1 by Vpx Is Independent of Uncoating.
    Jáuregui P; Logue EC; Schultz ML; Fung S; Landau NR
    J Virol; 2015 May; 89(10):5701-13. PubMed ID: 25762741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging role of the host restriction factor tetherin in viral immune sensing.
    Hotter D; Sauter D; Kirchhoff F
    J Mol Biol; 2013 Dec; 425(24):4956-64. PubMed ID: 24075872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a region within the cytoplasmic domain of the subtype B Vpu protein of human immunodeficiency virus type 1 (HIV-1) that is responsible for retention in the golgi complex and its absence in the Vpu protein from a subtype C HIV-1.
    Pacyniak E; Gomez ML; Gomez LM; Mulcahy ER; Jackson M; Hout DR; Wisdom BJ; Stephens EB
    AIDS Res Hum Retroviruses; 2005 May; 21(5):379-94. PubMed ID: 15929700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Function of human immunodeficiency virus type 1 Vpu protein in various cell types.
    Sakai H; Tokunaga K; Kawamura M; Adachi A
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2717-22. PubMed ID: 7595378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-induced SCYL2 limits release of HIV-1 by triggering PP2A-mediated dephosphorylation of the viral protein Vpu.
    Miyakawa K; Sawasaki T; Matsunaga S; Tokarev A; Quinn G; Kimura H; Nomaguchi M; Adachi A; Yamamoto N; Guatelli J; Ryo A
    Sci Signal; 2012 Oct; 5(245):ra73. PubMed ID: 23047923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles.
    Fitzpatrick K; Skasko M; Deerinck TJ; Crum J; Ellisman MH; Guatelli J
    PLoS Pathog; 2010 Mar; 6(3):e1000701. PubMed ID: 20221443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A single amino acid substitution within the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein renders simian-human immunodeficiency virus (SHIV(KU-1bMC33)) susceptible to rimantadine.
    Hout DR; Gomez LM; Pacyniak E; Miller JM; Hill MS; Stephens EB
    Virology; 2006 May; 348(2):449-61. PubMed ID: 16458946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retraction: Identification of calcium-modulating cyclophilin ligand as a human host restriction to HIV-1 release overcome by Vpu.
    Nat Med; 2010 Feb; 16(2):238. PubMed ID: 20134478
    [No Abstract]   [Full Text] [Related]  

  • 31. Shaping of the host cell by viral accessory proteins.
    Laguette N; Benkirane M
    Front Microbiol; 2015; 6():142. PubMed ID: 25755653
    [No Abstract]   [Full Text] [Related]  

  • 32. Reconfirming the Traditional Model of HIV Particle Assembly.
    Gross L
    PLoS Biol; 2006 Dec; 4(12):e445. PubMed ID: 20076520
    [No Abstract]   [Full Text] [Related]  

  • 33. Advances in HIV-1 Assembly.
    Lerner G; Weaver N; Anokhin B; Spearman P
    Viruses; 2022 Feb; 14(3):. PubMed ID: 35336885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis.
    Borrajo A; Spuch C; Penedo MA; Olivares JM; Agís-Balboa RC
    Ann Med; 2021 Dec; 53(1):43-69. PubMed ID: 32841065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type I Interferon Responses by HIV-1 Infection: Association with Disease Progression and Control.
    Soper A; Kimura I; Nagaoka S; Konno Y; Yamamoto K; Koyanagi Y; Sato K
    Front Immunol; 2017; 8():1823. PubMed ID: 29379496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FRET Analysis of the Promiscuous yet Specific Interactions of the HIV-1 Vpu Transmembrane Domain.
    Cole GB; Reichheld SE; Sharpe S
    Biophys J; 2017 Nov; 113(9):1992-2003. PubMed ID: 29117523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Various plus unique: Viral protein U as a plurifunctional protein for HIV-1 replication.
    Soper A; Juarez-Fernandez G; Aso H; Moriwaki M; Yamada E; Nakano Y; Koyanagi Y; Sato K
    Exp Biol Med (Maywood); 2017 Apr; 242(8):850-858. PubMed ID: 28346011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.
    Li G; De Clercq E
    Microbiol Mol Biol Rev; 2016 Sep; 80(3):679-731. PubMed ID: 27357278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of BST-2/Tetherin in host protection and disease manifestation.
    Mahauad-Fernandez WD; Okeoma CM
    Immun Inflamm Dis; 2016 Mar; 4(1):4-23. PubMed ID: 27042298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remodeling of the Host Cell Plasma Membrane by HIV-1 Nef and Vpu: A Strategy to Ensure Viral Fitness and Persistence.
    Sugden SM; Bego MG; Pham TN; Cohen ÉA
    Viruses; 2016 Mar; 8(3):67. PubMed ID: 26950141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.